MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2018 International Congress

    Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

    D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)

    Objective: This study was designed with the objective to find out the possible synergistic effect of Curcumin (Cur) and Methanolic extract of Ginkgo biloba (EGB)…
  • 2018 International Congress

    No MPTP-induced behavioral deficits or Striatal field potential alterations in crossbreds of MPTP-susceptible and MPTP-resistant mice strains

    P. Alladi, D. Vidyadhara, S. Arun, B. Kutty (Bengaluru, India)

    Objective: To evaluate the electrophysiological and motor behavioural correlates of strain-dependent differential susceptibility of mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the role of admixing thereon. Background:…
  • 2018 International Congress

    Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

    K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

    Objective: The aim of present study was to evaluate neuromodulatory propensity of Gingko Biloba in rotenone induced Mice Model of Parkinson Disease in terms of…
  • 2018 International Congress

    α-synuclein aggregation and propagation in marmoset brains deteriorates its motor function

    T. Yabumoto, K. Baba, H. Hayakawa, K. Ikenaka, F. Yoshida, T. Uehara, R. Nakatani, H. Tsuda, S. Nagano, H. Hamanaka, Y. Nagai, M. Hirata, H. Mochizuki. (Osaka, Japan)

    Objective: To confirm that α-synuclein aggregation and propagation in marmoset brains deteriorates its motor function. Background: Recently, the α-synuclein amyloid fibril is thought to be…
  • 2017 International Congress

    D2 receptor mediated DARPP32/PP1α signaling is responsible for cadmium induced Parkinson’s like behavioral alterations in rats

    R. Gupta, R. Shukla, V. Khanna (Luckno, India)

    Objective: To identify the specificity of dopamine D2 receptor mediated signaling in cadmium mediated motor alterations Background: Cadmium, a heavy metal, is to known to…
  • 2017 International Congress

    Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.

    N. Rocha, E. Furr-Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To evaluate predictors for psychosis in HD. Background: Behavioral problems are present across all stages of HD, even preceding the development of the motor…
  • 2017 International Congress

    Development of nano-formulation containing crocetin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds

    V. Kumar, A. Verma, P. Bhatt (Allahabad, India)

    Objective: Parkinson’s disease (PD) induced by the interaction between the number of factors viz., aging, genetics toxins, mitochondrial deformity and oxidative stress. Various evidences suggest…
  • 2017 International Congress

    Effects of different intensity exercises on motor function of PD rats as well as the regulation of DA

    x. Liu, p. Chen, d. Qiao, m. wang (Beijing, China)

    Objective: This paper research the intervention effect of the different intensity treadmill exercise on motor function of Parkinson 's diseases (PD) model rats,and explore the…
  • 2017 International Congress

    Non-motor symptoms in ACDY5-associated disease

    C. Amlang, M. Vidailhet, M. Amlang (Bronx, NY, USA)

    Objective: To describe non-motor symptoms in a case of ACDY5-associated disease. Background: The hereditary dyskinesia syndrome caused by an ACDY5 mutation was first described in…
  • 2017 International Congress

    Co-speech gestures in Parkinson’s disease (PD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: We develop an analytical description of co-speech gesture production in PD patients. Background: Communication and expressive behavior problems are frequent in PD patients (Duncan…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley